Stoke Therapeutics, Inc. STOK
NASDAQ · United States · Health Technology
$26.01+0.01 (+0.04%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | -0.93 | -0.80 | -17.0% | $9.33M | +90.7% | +9.7%$28.86→$31.67 |
| Q1 2026 | 2026-05-07 | -0.79 | -0.80 | +1.3% | — | — | -1.2%$33.28→$32.89 |
| Q4 2025 | 2026-03-16 | -0.97 | -0.74 | -31.1% | — | — | -1.0%$33.19→$32.87 |
| Q3 2025 | 2025-11-04 | -0.65 | -0.54 | -20.4% | — | — | -12.6%$26.10→$22.82 |
| Q2 2025 | 2025-08-12 | -0.40 | -0.54 | +25.9% | — | — | — |
| Q4 2024 | 2025-03-18 | -0.18 | -0.53 | +66.0% | — | — | — |
| Q3 2024 | 2024-11-05 | -0.47 | -0.54 | +13.0% | — | — | — |
| Q1 2024 | 2024-05-06 | -0.57 | -0.61 | +6.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.